Published in Proc Natl Acad Sci U S A on November 11, 2005
The telomere syndromes. Nat Rev Genet (2012) 4.01
Leukocyte telomere dynamics: longitudinal findings among young adults in the Bogalusa Heart Study. Am J Epidemiol (2008) 2.86
Syndromes of telomere shortening. Annu Rev Genomics Hum Genet (2009) 2.60
Human diseases of telomerase dysfunction: insights into tissue aging. Nucleic Acids Res (2007) 2.34
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One (2010) 2.19
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood (2008) 1.99
Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet (2009) 1.86
The genetics and clinical manifestations of telomere biology disorders. Genet Med (2010) 1.83
Low abundance of telomerase in yeast: implications for telomerase haploinsufficiency. RNA (2006) 1.74
Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest (2013) 1.58
The genetics of dyskeratosis congenita. Cancer Genet (2011) 1.50
Dyskeratosis congenita. FEBS Lett (2010) 1.36
Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis. PLoS Genet (2011) 1.29
Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene. Blood (2007) 1.26
Bone marrow failure and the telomeropathies. Blood (2014) 1.23
Lung alveolar integrity is compromised by telomere shortening in telomerase-null mice. Am J Physiol Lung Cell Mol Physiol (2008) 1.22
Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts. Aging Cell (2007) 1.20
Allele-specific relative telomere lengths are inherited. Hum Genet (2006) 1.18
Genome-wide association study of relative telomere length. PLoS One (2011) 1.16
Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations. PLoS One (2011) 1.16
Telomere length is inherited with resetting of the telomere set-point. Proc Natl Acad Sci U S A (2010) 1.15
Cell biology of disease: Telomeropathies: an emerging spectrum disorder. J Cell Biol (2014) 1.07
Dyskerin is a component of the Arabidopsis telomerase RNP required for telomere maintenance. Mol Cell Biol (2008) 1.06
Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndrome. Aging Cell (2007) 1.05
Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita. Blood (2008) 1.04
DNA damage responses and oxidative stress in dyskeratosis congenita. PLoS One (2013) 1.01
Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis. Chest (2015) 0.97
A common variant in the telomerase RNA component is associated with short telomere length. PLoS One (2010) 0.95
Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies. Curr Pharmacogenomics Person Med (2010) 0.87
Telomere-regulating genes and the telomere interactome in familial cancers. Mol Cancer Res (2014) 0.87
Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema. Sci Transl Med (2016) 0.85
No attenuation of the ATM-dependent DNA damage response in murine telomerase-deficient cells. DNA Repair (Amst) (2008) 0.84
Shortened leukocyte telomere length in type 2 diabetes mellitus: genetic polymorphisms in mitochondrial uncoupling proteins and telomeric pathways. Clin Transl Med (2016) 0.81
A mutation in the H/ACA box of telomerase RNA component gene (TERC) in a young patient with myelodysplastic syndrome. BMC Med Genet (2014) 0.81
Therapeutic opportunities: telomere maintenance in inducible pluripotent stem cells. Mutat Res (2011) 0.81
Attenuated expression of SECIS binding protein 2 causes loss of telomeric reserve without affecting telomerase. Exp Gerontol (2009) 0.80
Dyskeratosis congenita caused by a novel TERT point mutation in siblings with pancytopenia and exudative retinopathy. Pediatr Blood Cancer (2014) 0.78
The telomerase reverse transcriptase subunit from the dimorphic fungus Ustilago maydis. PLoS One (2014) 0.77
Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs. Biomed Res Int (2015) 0.75
Guardian of the Human Genome: Host Defense Mechanisms against LINE-1 Retrotransposition. Front Chem (2016) 0.75
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell (1985) 24.17
Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell (1997) 13.34
Telomerase catalytic subunit homologs from fission yeast and human. Science (1997) 12.35
Telomere reduction in human colorectal carcinoma and with ageing. Nature (1990) 11.24
Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A (1992) 10.19
The RNA component of human telomerase. Science (1995) 9.86
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature (2001) 7.95
A telomerase component is defective in the human disease dyskeratosis congenita. Nature (1999) 7.91
Essential role of mouse telomerase in highly proliferative organs. Nature (1998) 7.23
Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet (1994) 7.04
In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature (1990) 6.82
X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet (1998) 6.82
Structure and variability of human chromosome ends. Mol Cell Biol (1990) 6.18
The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell (2001) 5.98
Telomere states and cell fates. Nature (2000) 5.71
Regulation of telomerase by telomeric proteins. Annu Rev Biochem (2004) 5.69
Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res (1989) 4.72
Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet (2004) 4.63
A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end. Mol Cell Biol (1999) 4.51
Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med (1999) 4.27
Telomerase maintains telomere structure in normal human cells. Cell (2003) 3.29
Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J (1999) 3.29
Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet (1998) 2.87
Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis (2001) 2.69
Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc-/- mice with short telomeres. EMBO Rep (2001) 2.59
Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol (1998) 2.43
Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation (2002) 1.99
The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr Biol (2000) 1.97
Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice. Proc Natl Acad Sci U S A (2004) 1.83
Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance. Curr Mol Med (2005) 1.78
Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr Opin Genet Dev (2001) 1.78
Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA. Mol Cell Biol (2000) 1.42
The relative lengths of individual telomeres are defined in the zygote and strictly maintained during life. Aging Cell (2004) 1.42
Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging. EMBO J (2005) 1.38
Differences in telomere length between homologous chromosomes in humans. Nucleic Acids Res (2001) 1.34
Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. Blood (2004) 1.33
Dyskeratosis congenita: clinical and genetic heterogeneity. Report of a new case and review of the literature. Am J Pediatr Hematol Oncol (1992) 1.21
Segmental polymorphisms in the proterminal regions of a subset of human chromosomes. Genome Res (2002) 1.15
Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns. Br J Haematol (2000) 1.14
Dyskeratosis congenita, telomeres and human ageing. Trends Genet (2000) 1.02
Dyskeratosis congenita and telomerase. Curr Opin Pediatr (2004) 0.98
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature (2012) 14.33
The origin and evolution of mutations in acute myeloid leukemia. Cell (2012) 9.66
Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet (2004) 4.63
Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol (2008) 4.41
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. JAMA (2011) 4.11
Association between aplastic anaemia and mutations in telomerase RNA. Lancet (2002) 4.02
Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood (2005) 3.71
Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol (2012) 3.62
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood (2005) 3.30
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis (2005) 3.12
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia. Blood (2012) 2.77
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood (2007) 2.76
A genome-wide screen identifies the evolutionarily conserved KEOPS complex as a telomere regulator. Cell (2006) 2.71
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML. JAMA (2011) 2.61
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood (2007) 2.36
Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell (2008) 2.20
Characterization of apparently balanced chromosomal rearrangements from the developmental genome anatomy project. Am J Hum Genet (2008) 2.06
Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data. J Mol Diagn (2012) 2.02
Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci U S A (2004) 2.01
Functional conservation of the telomerase protein Est1p in humans. Curr Biol (2003) 2.00
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood (2008) 1.99
3'UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in mice. Blood (2011) 1.96
Disruption of ROBO2 is associated with urinary tract anomalies and confers risk of vesicoureteral reflux. Am J Hum Genet (2007) 1.85
Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice. Proc Natl Acad Sci U S A (2004) 1.83
Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients. Blood (2013) 1.82
The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA (2008) 1.81
Clinical next-generation sequencing in patients with non-small cell lung cancer. Cancer (2014) 1.76
Cells depleted for RPS19, a protein associated with Diamond Blackfan Anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production. Blood Cells Mol Dis (2007) 1.68
The retinoblastoma protein regulates pericentric heterochromatin. Mol Cell Biol (2006) 1.68
Short telomeres in ESCs lead to unstable differentiation. Cell Stem Cell (2013) 1.61
Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency. Blood (2004) 1.60
Mutations of the SBDS gene are present in most patients with Shwachman-Diamond syndrome. Blood (2004) 1.58
Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet (2003) 1.58
Flap endonuclease 1 contributes to telomere stability. Curr Biol (2008) 1.56
TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damage. Cell (2010) 1.50
The genetics of dyskeratosis congenita. Cancer Genet (2011) 1.50
Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP. J Mol Biol (2004) 1.39
Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert. Proc Natl Acad Sci U S A (2002) 1.38
A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice. Proc Natl Acad Sci U S A (2008) 1.37
Dyskeratosis congenita. FEBS Lett (2010) 1.36
Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol (2010) 1.35
Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. Blood (2004) 1.33
Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene (2002) 1.31
Dosage effects of cohesin regulatory factor PDS5 on mammalian development: implications for cohesinopathies. PLoS One (2009) 1.30
Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination. Proc Natl Acad Sci U S A (2009) 1.27
Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene. Blood (2007) 1.26
Aberrantly resolved RAG-mediated DNA breaks in Atm-deficient lymphocytes target chromosomal breakpoints in cis. Proc Natl Acad Sci U S A (2009) 1.25
Improvements in Medicare Part D risk adjustment: beneficiary access and payment accuracy. Med Care (2012) 1.16
Murine Pif1 interacts with telomerase and is dispensable for telomere function in vivo. Mol Cell Biol (2006) 1.16
Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome. J Pediatr Hematol Oncol (2006) 1.15
Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome. Proc Natl Acad Sci U S A (2013) 1.13
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells. Nat Cell Biol (2013) 1.12
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. N Engl J Med (2015) 1.10
Copy number variants and infantile spasms: evidence for abnormalities in ventral forebrain development and pathways of synaptic function. Eur J Hum Genet (2011) 1.08
Replication timing of human telomeres is chromosome arm-specific, influenced by subtelomeric structures and connected to nuclear localization. PLoS Genet (2010) 1.06
Human POT1 is required for efficient telomere C-rich strand replication in the absence of WRN. Genes Dev (2009) 1.05
Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndrome. Aging Cell (2007) 1.05
Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin. Nucleic Acids Res (2014) 1.05
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria. BMC Blood Disord (2004) 1.05
Dyskerin ablation in mouse liver inhibits rRNA processing and cell division. Mol Cell Biol (2009) 1.01
Recurrent deletions and reciprocal duplications of 10q11.21q11.23 including CHAT and SLC18A3 are likely mediated by complex low-copy repeats. Hum Mutat (2011) 1.01
ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complement. Mol Immunol (2004) 1.00
Clinical genomicist workstation. AMIA Jt Summits Transl Sci Proc (2013) 0.99
Long telomeres bypass the requirement for telomere maintenance in human tumorigenesis. Cell Rep (2012) 0.98
What's in a name? J Clin Invest (2012) 0.98
Murine hexose-6-phosphate dehydrogenase: a bifunctional enzyme with broad substrate specificity and 6-phosphogluconolactonase activity. Arch Biochem Biophys (2003) 0.98
Dyskeratosis congenita and telomerase. Curr Opin Pediatr (2004) 0.98
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica (2014) 0.97
Vault poly(ADP-ribose) polymerase is associated with mammalian telomerase and is dispensable for telomerase function and vault structure in vivo. Mol Cell Biol (2004) 0.97
TINF2 mutations in children with severe aplastic anemia. Pediatr Blood Cancer (2009) 0.97
Dyskerin, telomerase and the DNA damage response. Cell Cycle (2009) 0.96
Human telomerase RNA mutations and bone marrow failure. Lancet (2003) 0.96
Three major glucose-6-phosphate dehydrogenase-deficient polymorphic variants identified in Mazandaran state of Iran. Br J Haematol (2002) 0.95
Inherited surfactant deficiency caused by uniparental disomy of rare mutations in the surfactant protein-B and ATP binding cassette, subfamily a, member 3 genes. J Pediatr (2009) 0.95
Telomere length profiles in humans: all ends are not equal. Cell Cycle (2007) 0.93
Single-nucleotide polymorphism associations for colorectal cancer in southern chinese population. Chin J Cancer Res (2012) 0.91
Clinical utility gene card for: dyskeratosis congenita. Eur J Hum Genet (2011) 0.91
Resistance to the short term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration. J Biol Chem (2003) 0.90